Stocks in news: Ultratech, Paytm, L&T, Biocon, Alembic Pharma

[hfe_template id='11223'] [ad_1]
Markets traded within a narrow range on Friday and ended the day nearly unchanged despite an eventful session. In today's trade, shares of Ultratech, Paytm, L&T, Biocon, Alembic Pharma among others will be in focus due to various news developments.

L&T
Larsen and Toubro (L&T) has overturned a Rs 702 crore customs duty demand following a favourable ruling from the Central Excise & Service Tax Appellate Tribunal.


EaseMyTrip
EaseMyTrip signed a share purchase agreement to acquire 49% stake in Pflege for Rs 30 crore.

Biocon
Biocon received EIR With VAI Status From US FDA For Its API facility (Site 2), Bengaluru.


Read more: Here's the trade setup for today's session

Poonawalla Fincorp
Dhiraj Saxena resigned as the Chief Technology Officer (CTO) due to harassment and unnecessary interventions of CHRO.Paytm
Paytm Singapore will sell its stock acquisition rights (SARs) in Japanese payments firm PayPay for net proceeds of JPY 41.9 billion (equivalent to Rs 2,364 crore).Ultratech
India Cements comments on CCI notice on UltraTech Cement deal. The company is in process of furnishing response to CCI in this regard and will be able to satisfy the concerns the CCI may have as the cement market is extremely competitive.

Alembic Pharma
Alembic Pharma dissolved six step-down subsidiaries, namely Okner Realty LLC, Alembic Labs LLC, Alnova Pharmaceuticals SA, Dahlia Therapeutics SA, Genius LLC & Alembic Mami SpA.

Laurus Labs
Laurus Labs board approved an investment of Rs 40 crore in Arm Laurus Bio.

Star Health
Star Health received a show cause notice (SCN) from Irdai for non-compliance with various regulations and guidelines.

CEAT
CEAT will acquire Camso brand Off-Highway Tyres and Tracks Business from Michelin for $225 million.

[ad_2] Source link https://mrgaga.in/stocks-in-news-ultratech-paytm-lt-biocon-alembic-pharma/?feed_id=45070&_unique_id=67565707460e1

Comments

Post a Comment

Popular posts from this blog

India VIX jumps 100% in one month. Could fear levels take Nifty further down?

Image
[hfe_template id='11223'] [ad_1] Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
Read more

Can Sensex, Nifty snap 2-day fall on Monday? 7 factors that could decide market mood this week

Image
[hfe_template id='11223'] [ad_1] Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
Read more

Waaree Energies shares in focus after Q4 profit rises 34% to Rs 619 crore, revenue up 36%

Image
[hfe_template id='11223'] [ad_1] Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
Read more